Diabetes and cardiovascular disease

Zimmet, Prof. P., Mellbourne, Australia HbA1c for Diagnosis of Diabetes – What are we gaining, what are we losing?(Archiv) 19-Oct-09

Ceriello, Prof. A., Barcelona, Spain Is HbA1c sufficient for the evaluation of hyperglycemia-related CVD risk in diabetes?(Archiv) 19-Oct-09

Tuomilehto, Prof. J., Helsinki, Finland Hypoglycemia as a CV-risk factor(Archiv) 19-Oct-09

Ceriello, Prof. A., Barcelona, Spain Postprandial hyperglycaemia as a driving force in diabetes and CVD(Archiv) 18-Oct-09

Holman, Prof. R., Oxford, United Kingdom The Acarbose Cardiovascular Evaluation (ACE) study - secondary prevention of CVD in prediabetes(Archiv) 18-Oct-09

Chiasson, Prof. J.-L., Montréal, Canada Glucose lowering interventions in diabetes and CVD - lessons from outcome studies(Archiv) 18-Oct-09

Josse, Prof. R., Toronto, Canada Acarbose - safe and effective glycaemic control with cardiovascular benefits(Archiv) 18-Oct-09

Schnell, Prof. O., Munich, Germany Recent guideline recommendations for managing pre- and established diabetes and CVD(Archiv) 18-Oct-09

Chiasson, Prof. J.-L., Montréal, Canada Summary and conclusions(Archiv) 18-Oct-09

Erdmann, Prof. E., Köln, Germany Acute Treatment of Cardiovascular Disease(Archiv) 29-Aug-08

Böhm, Prof. M., Homburg/Saar, Germany Heart Failure in Diabetes(Archiv) 29-Aug-08

Ceriello, Prof. A., Barcelona, Spain Postpranial hyperclycaemia as a driving force in diabetes and CVD - epidemiological evidence & molecular insights(Archiv) 01-Jun-08

Rydén, Prof. L., Stockholm, Sweden Two sides of the same coin - guideline recommendations for managing diabetes and CVD(Archiv) 01-Jun-08

Satman, Prof. I., Turkey Screening and intervention programmes to prevent diabetes and CVD - an example from daily practice(Archiv) 01-Jun-08

Jellinger, Dr. P., Miami, United States Target Glycaemic Control: Two Experts` Perspectives(Archiv) 17-Oct-07

Gerstein, Prof. H. C., Hamilton, Canada Glycemic Control & CVD: What does the Evidence Show? What answers are on the Horizon?(Archiv) 17-Oct-07

Kaufman, MD F., Childrens Hospital Los Angeles, Los Angeles, United States Our Children with Diabetes: Hearts at Risk(Archiv) 27-Sep-07

Standl, Prof. E., Munich, Germany New Coaching Techniques(Archiv) 18-Sep-07

Holman, Prof. R., Oxford, United Kingdom CVD Risk Reduction In Prediabetes - Impact of Recent Studies and of the ACARBOSE CARDIOVASCULAR EVALUATION (ACE) Trial(Archiv) 17-Sep-07

Chiasson, Prof. J.-L., Montréal, Canada Managing Dysglycemia And CVD - Exploring Current Treatment Options(Archiv) 17-Sep-07

Rosas, Dr. J., Mexico Latin American Experience(Archiv) 17-Sep-07

Chiasson, Prof. J.-L., Montréal, Canada North American Experience(Archiv) 17-Sep-07

Shaw, Dr. J., Australia Asian Experience(Archiv) 17-Sep-07

Tuomilehto, Prof. J., Helsinki, Finland European Experience(Archiv) 17-Sep-07

Bartnik, Dr. M., Stockholm, Sweden Definition and classification of diabetes and pre-diabetic glucose abnormalities(Archiv) 29-Jun-07

Tuomilehto, Prof. J., Helsinki, Finland Identification of subjects at high risk for cardiovascular disease or diabetes(Archiv) 29-Jun-07

Standl, Prof. E., Munich, Germany Treatment to reduce cardiovascular risk: Life style counselling and glycemic control(Archiv) 29-Jun-07

Östergren, Prof. J., Stockholm, Sweden Treatment to reduce cardiovascular risk: Hypertension and dyslipidemia(Archiv) 29-Jun-07

Malmberg, Prof. K., Stockholm, Sweden Management of cardiovascular diseases: Acute coronary syndromes(Archiv) 29-Jun-07

Rydén, Prof. L., Stockholm, Sweden Management of cardiovascular disease: Coronary interventions(Archiv) 29-Jun-07

Östergren, Prof. J., Stockholm, Sweden Management of cardiovascular diseases: Peripheral and cerebrovascular disease(Archiv) 29-Jun-07

Vahanien, Prof. A., Paris, France Guideline distribution and adherence in a general perspective(Archiv) 29-Jun-07

Chiasson, Prof. J.-L., Montréal, Canada Acarbose – a proven role in prediabetes and beyond(Archiv) 03-Dec-06

Holman, Prof. R., Oxford, United Kingdom CVD risk reduction in prediabetes – current and future outcome trials(Archiv) 03-Dec-06

Rydén, Prof. L., Stockholm, Sweden Dysglycaemia and CVD – the deadly duo(Archiv) 03-Dec-06

Hu, Prof. D., Peking, China Halting disease progression – the need for early intervention(Archiv) 03-Dec-06

Chiasson, Prof. J.-L., Montréal, Canada Glucobay® – treating dysglycaemia and reducing CVD risk(Archiv) 03-Dec-06

Holman, Prof. R., Oxford, United Kingdom A new outcome trial with Glucobay® – further investigation in diabetes and CVD prevention(Archiv) 03-Dec-06

Ruilope, Prof. L., Madrid, Spain Nifedipine GITS - a time for ACTION in diabetes patients(Archiv) 05-Sep-04

Alberti, Prof. Sir G., London, United Kingdom Type 2 Diabetes and CVD - a tale of two diseases?(Archiv) 05-Sep-04

Haffner, Prof. S., San Antonio, United States Acarbose - a first-line therapy to break the CVD connection(Archiv) 05-Sep-04

Armitage, Prof. J., Oxford, United Kingdom The role of Aspirin™ for CV risk reduction in diabetes(Archiv) 05-Sep-04

Hanefeld, Prof. M., Dresden, Germany Normalizing glucose metabolism along the diabetes continuum - benefits beyond metabolic control(Archiv) 28-Aug-03

Holman, Prof. R., Oxford, United Kingdom Chairman´s welcome and objectives(Archiv) 28-Aug-03

Josse, Prof. R., Toronto, Canada Reducing the risk of cardiovascular events in diabetes - evidence based options(Archiv) 28-Aug-03

Karasik, Prof. A., Tel Hashomer, Israel Prevention of CV events in diabetics by antiplatelet therapy(Archiv) 28-Aug-03